Get started

Stockstowatch

Astec Lifesciences trying to close above mid channel resistnace.Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. Its products include Tebuconazole, Propiconazole, Hexaconazole, and Difenoconazole. Astec LifeSciences Ltd CMP is 1287.05. The positive aspects of the company are Growth in Net Profit with increasing Profit Margin (QoQ) and Company with Zero Promoter Pledge. The Negative aspects of the company are MFs decreased their shareholding last quarter, Degrowth in Revenue and Profit and Annual net profit declining for last 2 years. Entry can be taken after closing above 1309. Targets in the stock will be 1356 and 1406. The long-term target in the stock will be 1469. Stop loss in the stock should be maintained at Closing below 1247. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:ASTECLong
by Happy_Candles_Investment
Escorts Kubota trying to bounce after fall and consolidation. Escorts Kubota Ltd. manufactures and supplies agricultural machinery, auto suspension and ancillary products and railway equipment. It operates through the following segments: Agri Machinery Products, Construction Equipment, Railway Equipment and Others. The Agri Machinery Products segment manufactures tractors, lubricants, engine and gensets; and provides crop solutions. The Construction Equipment segment manufactures and markets construction and material handling equipment like cranes, loaders, vibratory rollers, and forklifts. The Railway Equipment segment manufactures railway components, which includes brakes and brake systems, couplers, rail fastening systems, and automatic twist locks. Escorts Kubota Ltd CMP is 4014.95. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding AND MFs increased their shareholding last quarter. The Negative aspects of the company are High PE (PE=42.3), Declining Net Cash Flow : Companies not able to generate net cash, Companies with high market cap, lower public shareholding AND Increasing Trend in Non-Core Income. Entry can be taken after closing above 4020. Targets in the stock will be 4081 and 4191. The long-term target in the stock will be 4305. Stop loss in the stock should be maintained at Closing below 3855. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:ESCORTSLong
by Happy_Candles_Investment
Kernex Microsystems High Risk but having potential. Kernex Microsystems India Ltd. engages in the manufacture and sale of safety systems and software services for railways. Its products include TrainSHIELD, ACD, LxGuard, SAFELx, CASRY, ATRW, and KTPIS. Kernex Microsystems India Ltd CMP is 511.45. The positive aspects of the company are Company with Low Debt, Consistent Highest Return Stocks over Five Years - Nifty500. The Negative aspects of the company are declining profits, declining net cash flow and a negative PE. Promoter pledges are also high. Entry can be taken after closing above 515. Targets in the stock will be 554 and 584. The long-term target in the stock will be 633 and 670. Stop loss in the stock should be maintained at Closing below 446 or 384 depending on your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:KERNEXLong
by Happy_Candles_Investment
JB Chem Pharma looking to climb upwards.J B Chemicals & Pharmaceuticals (JBC) is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. JBC has its subsidiaries namely Lekar Healthcare Ltd and J.B Life Science Overseas Ltd. J B Chemicals & Pharmaceuticals CMP is 1800.15. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge and FII / FPI or Institutions increasing their shareholding. The Negative aspects of the company are High PE (PE=50.6), MFs decreased their shareholding last quarter, Promoter decreasing their shareholding and Companies not able to generate net cash. Entry can be taken after closing above 1807. Targets in the stock will be 1843 and 1893. The long-term target in the stock will be 1934. Stop loss in the stock should be maintained at Closing below 1673 or 1625 depending on your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:JBCHEPHARMLong
by Happy_Candles_Investment
Dutch Bros (BROS) Analysis Drive-Thru Coffee Experience: Dutch Bros NYSE:BROS operates drive-thru coffee shops in the U.S., offering bold beverages and emphasizing friendly service and a fun atmosphere. During inflationary periods, Dutch Bros' cheaper prices compared to Starbucks attract cost-conscious consumers. Leadership and Growth Potential: The new CEO, Christine Barone, with her extensive experience at Starbucks, is expected to drive the next growth phase for the company. Her leadership is anticipated to enhance operational efficiency and expand Dutch Bros' market presence. Investment Outlook: Bullish Outlook: We are bullish on BROS above the $37.00-$38.00 range. Upside Potential: With an upside target set at $55.00-$56.00, investors should consider Dutch Bros' competitive pricing and strategic leadership as key drivers for future stock appreciation. 📊☕ Monitor Dutch Bros for promising investment opportunities! #BROS #CoffeeMarket 📈🔍
NYSE:BROSLong
by Richtv_official
Globus Sprits in high sprits. Globus Spirits Ltd. operates as a holding company, which engages in the manufacture and sale of Indian made Indian liquor, bulk alcohol and franchise bottling. Globus Spirits Ltd CMP is 847.45. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding and MFs increased their shareholding last quarter. The Negative aspects of the company are High PE (PE=45), Declining Net Cash Flow : Companies not able to generate net cash and Annual net profit declining for last 2 years. Entry can be taken after closing above 876. Targets in the stock will be 936 and 991. The long-term target in the stock will be 1093 and 1196. Stop loss in the stock should be maintained at Closing below 777. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:GLOBUSSPRLong
by Happy_Candles_Investment
GMM Pfaudler on the verge of a BO after forming double bottom. GMM Pfaudler Ltd. engages in the design, manufacture, and market of chemical processing equipment, which are used in the pharmaceutical, specialty chemicals, agro chemicals, and chemical processing industries. It operates through the following business segments: Glass Lined Equipment; Heavy Engineering; Mixing Systems; Engineered Systems & Acid Recovery; and Filtration and Drying. The firm also offers flouro-polymer products and other equipment such as agitated filter driers, and wiped film evaporators. GMM Pfaudler Ltd. CMP is 1457.10. The positive aspects of the company are Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, rising net cash flow and cash from operating activity and MFs increased their shareholding last quarter. The Negative aspects of the company are decline in Revenue and profits. Entry in can be taken after closing above 1467. Targets in the stock will be 1526 and 1571. The long-term target in the stock will be 1653 and 1718. Stop loss in the stock should be maintained at Closing below 1233 or 1143 depending on your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:GMMPFAUDLRLong
by Happy_Candles_Investment
TSLA | TESLA is OvervaluedTesla, Inc.'s second quarter earnings confirm our view that the stock is one of the most overvalued stocks in the market. Tesla's stock has been rising this year amid a sudden shift in overall market sentiment, with many investors now pricing in a soft-landing scenario after a brutal past year of Federal Reserve rate hikes. But the shift in market sentiment doesn't change the fact that Tesla's stock fundamentals are completely disconnected from reality. Tesla is a terribly overvalued stock that we think is worth closer to $26 per share instead of its current price of about $290 per share. While Tesla is profitable, its profits are nowhere near the levels needed to justify its current valuation. We recognize that Tesla's business generates an impressive return on invested capital (ROIC), which is a key measure of profitability, especially for an automaker. However, that ROIC is already declining in the trailing-twelve-month (TTM) period. Using our reverse discounted cash flow (DCF) model, we find that for the stock to have any upside at current levels, Tesla must improve its ROIC to levels not achieved by even the most profitable businesses in the world . Figure 1 shows Tesla's historical ROIC along with the future ROIC implied by its current stock price. We provide the assumptions behind this DCF scenario later in this report. Tesla's latest earnings continue to show that it is not immune to competitive challenges and will likely see lower profitability in the future. But, its valuation implies the opposite. Any investor with fiduciary duties should be aware of the growing disconnect between Tesla's current fundamentals and the future fundamentals implied by its stock price. Even in an optimistic future cash flow scenario, shares could trade as low as $26/share. All the details are below. Supply Constrained Argument Is Gone: Bulls have long argued that demand for Tesla vehicles has always exceeded the supply of vehicles. However, Tesla's multiple price cuts in 2023, along with its lackluster production levels through the first half of 2023, raise questions about just how much demand there is for Tesla vehicles, especially amid competition from rivals Ford (F), General Motors (GM) and virtually every other automaker. Q2 2023 marks Tesla's fifth consecutive quarter in which vehicles produced were greater than vehicles delivered. Tesla is no longer selling every vehicle it can make. Should demand for EVs slow, Tesla could find itself with higher than wanted inventory levels, which could lead to further price cuts and additional pressure on already falling margins. Continued Cash Burn: Despite Tesla's top line growth, it continues to burn massive amounts of cash. Over the past five years, Tesla has burned a cumulative $4.2 billion in free cash flow (FCF), including $3.6 billion over the trailing-twelve months (TTM) alone. Tesla has generated negative FCF in all but one year (2019) of its existence as a public company. Margin Decline: Tesla's "GAAP gross margin" was 18.2% in 2Q23, down from 19.3% in 1Q23 and 25.0% in 2Q22. 2Q23's GAAP gross margin was below expectations of 18.7% and remains at its lowest level since 4Q20. Tesla's operating margin is also moving the wrong direction as it scales up. After selling 211 thousand more vehicles in 2Q23 compared to 2Q22, Tesla's reported operating margin fell 493 basis points YoY in 2Q23. Tesla noted in its press release that reduced average selling prices were one of the items that impacted margins in the quarter. We would expect Tesla's margins to fall further as competition limits pricing power across the industry. While Tesla has rapidly ramped up vehicle production and deliveries, its market share must increase almost exponentially to justify the expectations baked into its stock price. However, as it stands, Tesla holds a meager share of the global auto industry, and its share of the EV market ranks behind incumbents across Europe and China. In Europe, based on sales from May 2023, Tesla holds a 12% share of the EV market, much lower than VW Group (20%) and Stellantis (STLA) at (14%).In China, also based on sales from May 2023, Tesla holds 9% of the EV market compared to a staggering 38% share for top competitor BYD. Bulls have long argued that Tesla isn't just an automaker, but rather a technology company with multiple verticals such as insurance, solar power, housing, and, yes, robots. We've long refuted these bull dreams. Regardless of the promises of developing multiple business lines, Tesla's business remains concentrated in its auto segment. Auto revenue accounted for 86% of Tesla's TTM revenue as of 2Q23.Tesla can no longer enjoy its first mover advantage as many other major automakers are producing electric vehicles. These competitors have more experience in auto production and more resources and cash flow than Tesla to invest in the electric vehicle market. Tesla is at risk of losing market share to its competitors in the electric vehicle space and its stock price is currently not reflecting that, which is a major risk for investors. Since bottoming out at the beginning of the year, the stock has come up almost 200%, stopping just shy of $300. One could say the recent selloff is due to the earnings, but technical analysis would have suggested that a selloff was due even before the earnings. Firstly, we can see that a significant bearish divergence has been building in the RSI since June. Furthermore, we have been nearing an important area of trade as highlighted by the red rectangle. The $300 level has been a key area of trade, and you’d expect to see some resistance. So if a pullback has begun where can we expect it to end? As I see it, we have formed an initial ABC structure from the lows in wave 1 of a five-wave impulse. This means that wave ii could now take us down to the 61.8% retracement of this rally, which lands us at $198. We can see that this is also a very important area of support, as shown by the Visible Range Volume Profile. And, of course, we have the 200 day Moving Average offering support around this level, too.
NASDAQ:TSLA
by moonypto
Can Indiamart move above the dart?IndiaMART InterMESH Ltd. engages in the provision of platform to Small and Medium Enterprises, large enterprises, as well as individuals. India's largest online B2B marketplace, IndiaMART is at the forefront of transforming the landscape to facilitate ease of doing business through a well-entrenched network of hi-tech solutions and services. IndiaMART InterMESH Ltd. CMP is 2717.65. The positive aspects of the company are Mutual Funds Increased Shareholding, Annual Profit Growth higher than Sector Profit Growth, Company with No Debt, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding and Growth in Net Profit with increasing Profit Margin. The Negative aspects of the company are High PE (PE=48.8) and Companies with growing costs YoY for long term projects. Entry can be taken after closing above 2742. Targets in the stock will be 2814 and 2857. The long-term target in the stock will be 2917, 2962 and 3018. Stop loss in the stock should be maintained at Closing below 2549 or 2399 depending on your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:INDIAMARTLong
by Happy_Candles_Investment
Can IPCA Break the trend?Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca Laboratories Ltd CMP 1220.75. The positive aspects of the company are Mutual Funds Increased Shareholding in Past Month, Company with Low Debt, Company with Zero Promoter Pledge and FII / FPI or Institutions increasing their shareholding. The Negative aspects of the company are High PE (PE=56.6), MFs decreased their shareholding last quarter, Declining Net Cash Flow : Companies not able to generate net cash and De-growth in Revenue, Profits and Operating Profit Margin in recent results. Entry can be taken after closing above 1225. Targets in the stock will be 1252 and 1294. The long-term target in the stock will be 1328 and 1357. Stop loss in the stock should be maintained at Closing below 1136. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:IPCALABLong
by Happy_Candles_Investment
Teamlease can try to cross the next hurdlesTeamLease Services Ltd. engages in the provision of staffing solutions. It operates through the following segments: General Staffing and Allied Services; and Other Human Resource Services. The General Staffing and Allied Services segment comprises of staffing operations, temporary recruitment and payroll. TeamLease Services Ltd CMP is 3006.85. The positive aspects of the company are Company with Low Debt, Company able to generate Net Cash - Improving Net Cash Flow, FII / FPI or Institutions increasing their shareholding and Annual Net Profits improving. The Negative aspects of the company are MFs decreased their shareholding last quarter, High PE (PE=45), High promoter stock pledges and Decline in Net Profit margin. Entry can be taken after closing above 3036. Targets in the stock will be 3194 and 3348. The long-term target in the stock will be 3532 and 3710. Stop loss in the stock should be maintained at Closing below 2733. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:TEAMLEASELong
by Happy_Candles_Investment
Bajaj Healthcare can remain bullish on buy back offerBajaj Healthcare Ltd. is a pharmaceutical company, which engages in the development, manufacturing, and supply of amino acids, nutritional supplements, and active pharmaceutical ingredients, serving various Pharmaceuticals, Nutraceuticals and Food industries globally. Bajaj Healthcare Ltd CMP is 355. The positive aspects of the company are Company with Zero Promoter Pledge, Mutual Funds Increased Shareholding in Past Month and Increasing Revenue every quarter for the past 2 quarters. The Negative aspects of the company are declining Net Cash Flow : Companies not able to generate net cash. Entry can be taken after closing above 359. Targets in the stock will be 377. The long-term target in the stock will be 403, 429 and 447. Stop loss in the stock should be maintained at Closing below 312. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:BAJAJHCARELong
by Happy_Candles_Investment
Maithan can make smart movesMaithan Alloys Ltd. manufactures and exports manganese alloys. Its products include Ferro silicon, Ferro manganese, and silicon manganese. The firm also generates and supplies wind power. Maithan Alloys Ltd CMP is 1212.15. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge, MFs increased their shareholding last quarter, Companies with 10% increase in share price over three months, with rising net profit growth and Companies with rising net profit margins. The Negative aspects of the company are Inefficient use of capital to generate profits, Degrowth in Revenue and Profit, Declining Net Cash Flow : Companies not able to generate net cash and Annual net profit declining. Entry can be taken after closing above 1223. Targets in the stock will be 1267 and 1307. The long-term target in the stock will be 1351. Stop loss in the stock should be maintained at Closing below 1126. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:MAITHANALLLong
by Happy_Candles_Investment
UPL :: Turning around to (Agrow)Chemical Stock? - It's been decades we have seen that AgriCulture is contributing almost about 18-20% in India's GDP growth yet this sector remains to be more politically inclined to their specific actions during major elections. - GDP contribution by Top 3 sectors: Agriculture: 18.4% Industry: 28.3% Services: 53.3% - NSE:UPL is one of the top 5 global providers of total agricultural solutions with a footprint in 138+ countries. Going by the current situation we see the following observations - 1) Script is trading at a Money-based range dating back to the pandemic lows after hitting 52W Lows due to global headwinds. 2) After a stellar doubler move from Dec'20 to May'21 the script delivered almost more than 100% return to its investors and eventually we see a exhaustion after an eventual double top like pattern with a neckline candle marked in a red zone. 3) Interestingly, you see a SWAP LEVEL marked to denote the beautiful Yearly Low of 2021 being protected for next 2yrs and finally breaks down nearing ending of 2022 while being in a range of 200p within the red zone and swap level for that existing period. 4) While, we talked about price action in the previous point we missed out the lethal info being nudged in by our FUNDFLUX tool which showed consistent outflow of money in first 2Q's of 2022 before it out the swap level in Q3 of 2022. 5) What happens next will make you understand why we call the marked blue dotted line as the "Swap level" as after the breakdown we see a retest of the same level now turning out to be a resistance for script and eventually the Yearly Pivot Level of 2024 . 6) Now, currently the script trades in a good money-based range eventually dodging out YL4 breakdown and here the risk seems to be minimum as per the return is concerned as after 510-520 the script will be ripped for 640-650 initial target making a return of 30-35% in cash from entry being in the marked money-based green range and it can be in news in this quarter as elections are nearing and as said in the beginning - "AgriCulture" will be on one of the top agendas of the political parties and alongside if we see a relief from destocking and price revisions in the West after the much anticipated rate cuts then it will be an icing on the cake for the script as margins will improve in the coming quarterly results and lastly monsoon season is about to begin in India in a month and till now SKYMET expects Monsoon to be 'normal' in India. A RELEVANT ARTICLE - www.livemint.com
NSE:UPL
by PivotMinati
1
Lupin can take a leap.Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the business of producing, developing, and marketing a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporin segments. Lupin Ltd. CMP is 1621.35. The positive aspects of the company are Company with Low Debt, Annual Net Profits improving for last 2 years, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding and Efficient in managing Assets to generate Profits. The Negative aspects of the company are Declining Net Cash Flow : Companies not able to generate net cash, MFs decreased their shareholding last quarter and Promoter decreasing their shareholding. Entry can be taken after closing above 1636. Targets in the stock will be 1657 and 1677. The long-term target in the stock will be 1700 and 1728. Stop loss in the stock should be maintained at Closing below 1545 or 1497 depending on your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:LUPINLong
by Happy_Candles_Investment
JK Tyre is jumping after forming a baseJK Tyre & Industries Ltd. manufactures tyres, tubes and flaps. JK Tyre & Industries Ltd is one of the leading automotive tyre manufacturers in India. The company mainly develops, manufactures, markets and distributes automotive tyres, tubes, flaps and retreads. It markets tyres for sale to vehicle manufacturers for fitment as original equipment and for sale in replacement markets. The company has manufacturing plants located in India and Mexico with worldwide distribution. JK Tyre & Industries Ltd CMP is 429.75. The positive aspects of the company are Company reducing Debt, Company with Zero Promoter Pledge, Annual Net Profits improving and Improving Cash Flow from operation. The Negative aspects of the company are MFs decreased their shareholding last quarter, Companies not able to generate net cash and Increasing Trend in Non-Core Income. Entry can be taken after closing above 434. Targets in the stock will be 446, 471, 486 and 500. The long-term target in the stock will be 515, 534 and 554. Stop loss in the stock should be maintained at Closing below 382 or 359 depending on your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:JKTYRELong
by Happy_Candles_Investment
Bajaj Finserv again looking good to go longBajaj Finserv Ltd. is a holding company involves in lending, insurance, and wealth advisory businesses. It operates through the following segments: Life Insurance, General Insurance, Windmill, Retail Financing, and Investments and Others. It is also the holding company for generation of Electric power through conventional and unconventional methods. Negative aspects of the company are high PE, High promoter stock pledges and company not able to generate enough cash through operations. There were increased provisions for NPA during the recent results. Positive aspects of the company are MFs increased stake in the company in past month, company reducing debt, FIIs increasing stake in the company and increasing revenues since last 3 quarters. Entry can be taken after closing above 1613. Targets in the stock will be 1633 and 1663. The long-term target in the stock will be 1692 and 1724. Stop loss in the stock should be maintained at Closing below 1515 on a weekly closing. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:BAJAJFINSV
by Happy_Candles_Investment